8:52 AM ET
8-K
Investor Presentation
Axogen Investor Presentation
Axogen, Inc. filed a corporate presentation and hosted an investor event on November 9, 2026, to announce its decision to move forward with a commercial market launch for prostate nerve reconstruction. The presentation highlights the clinical need and market opportunity for using Avance Nerve Allograft to restore erectile function and quality of life following robotic-assisted radical prostatectomies.